Purple Biotech Ltd.
PPBT | NASDAQ
$1.22
+$0.07 (+6.09%)
Nov 2, 2026, 11:17 AM ET · Market open
Market Data
Market Cap $168.46K
Enterprise Value $-5.81M
Beta -0.55
Average Volume 1.04M
Shares Outstanding (Diluted) 10.86M
Shares Change YoY 296.93%
Institutional Ownership 0.78%
Exchange NASDAQ
ISIN US74638P3073
Price Performance
Price Change 1M -19.2%
Price Change 3M -17.0%
Price Change 6M -71.1%
Price Change YTD -81.4%
Price Change 1Y -85.8%
Price Change 3Y -99.5%
Price Change 5Y -99.9%
1M CAGR (ann.) -18.8%
1Y CAGR (ann.) -89.0%
5Y CAGR (ann.) -73.5%
All-Time CAGR -58.0%
Valuation
PE Ratio -0.51
Forward PE N/A
PEG Ratio 0.00
Forward PEG 0.00
PS Ratio N/A
Forward PS 0.00
PB Ratio 0.01
P/FCF Ratio -0.02
P/Adj. FCF Ratio -0.02
P/OCF Ratio -1.61
EV/Sales N/A
EV/EBIT 0.24
EV/EBITDA 0.24
EV/FCF 0.75
Earnings Yield -196.5%
FCF Yield -4974.5%
Adj. FCF Yield -5177.7%
Financial Health
Net Cash $6.11M
Total Debt $134K
Cash & Short-Term Investments $6.11M
Total Assets $14.17M
Current Ratio 3.72
Quick Ratio 3.72
Debt / Equity Ratio 0.01
Debt / EBITDA -0.01
Debt / FCF -0.02
OCF / Debt -57.90
Interest Coverage -116.29
Altman Z-Score -22.13
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -4.1%
Returns
Return on Assets -172.9%
Return on Equity -151.8%
Return on Invested Capital -241.9%
Return on Capital Employed -247.1%
Return on Tangible Assets -360.0%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y -30.7%
EPS CAGR 3Y 98.5%
EPS CAGR 5Y 50.1%
EPS CAGR 10Y 40.9%
FCF CAGR 3Y 43.5%
FCF CAGR 5Y 19.1%
FCF CAGR 10Y -4.6%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 1
EPS Growth Next 3Y 27.8%
Revenue Growth Next 3Y N/A
Earnings Date Nov 13, 2026
EPS Estimate (next Q) -$2.88
EPS Growth Est (next Q) -0.7%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $17.00
Price Target Upside 1404.4%
Cash Flow
Operating Cash Flow $-7.76M
Free Cash Flow $-7.76M
Adj. Free Cash Flow $-8.08M
FCF Per Share -$0.71
OCF Per Share -$0.70
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-28.36M
EBITDA $-24.28M
Net Income $-24.49M
EPS (Diluted) -$2.22
Revenue / Employee N/A
Profit / Employee $-2.45M
Employees 10
Add to Watchlist
Select watchlists to add or remove PPBT